Ledger.Open graph →
SEC Form D · filed April 22, 2021

Revelation Biosciences, Inc

Offering
$4.4M
Sold
$4.4M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SAN DIEGO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (17)

George F. Tidmarsh · San Diego, CADirectorJennifer F. Carver · San Diego, CADirectorCurt F. Labelle · San Diego, CADirectorJess F. Roper · San Diego, CADirectorJames M. Rolke · San Diego, CAExec · DirectorDoonaye Sookye · Morc St Andre, O4DirectorJulian N. Fletcher · Grand Cayman, Cayman IslandsDirectorRajan Lukose · Oakland, CADirectorNavus Capital Management LP · Oakland, CADirectorDavid Welch · Oakland, CAExec · DirectorChester S. Zygmont · Menlo Park, CAExecGrethe Moen · Oslo, Q8DirectorJan Schoolmeesters · Oslo, Q8DirectorSven Borre Larsen · Oslo, Q8Exec · DirectorChristopher Finlayson · Oslo, Q8DirectorMatt Blodgett · San Francisco, CADirectorChester S. Zygmont · Menlo Park, CAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗